NM_001374828.1:c.1791+19G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001374828.1(ARID1B):​c.1791+19G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0032 in 1,339,434 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0033 ( 13 hom. )

Consequence

ARID1B
NM_001374828.1 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.51

Publications

1 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
MIR4466 (HGNC:41726): (microRNA 4466) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 6-156779490-G-C is Benign according to our data. Variant chr6-156779490-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0024 (358/149450) while in subpopulation NFE AF = 0.0036 (241/66922). AF 95% confidence interval is 0.00323. There are 1 homozygotes in GnomAd4. There are 180 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 358 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.1791+19G>C intron_variant Intron 1 of 19 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.1791+19G>C intron_variant Intron 1 of 19 2 NM_001374828.1 ENSP00000490491.2 Q8NFD5-3A0A6Q8NVI4

Frequencies

GnomAD3 genomes
AF:
0.00240
AC:
358
AN:
149340
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000414
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00186
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00716
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00360
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00251
AC:
243
AN:
96716
AF XY:
0.00259
show subpopulations
Gnomad AFR exome
AF:
0.000215
Gnomad AMR exome
AF:
0.00120
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00997
Gnomad NFE exome
AF:
0.00273
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00330
AC:
3925
AN:
1189984
Hom.:
13
Cov.:
33
AF XY:
0.00323
AC XY:
1895
AN XY:
587426
show subpopulations
African (AFR)
AF:
0.000421
AC:
10
AN:
23762
American (AMR)
AF:
0.00124
AC:
22
AN:
17812
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27040
South Asian (SAS)
AF:
0.00195
AC:
103
AN:
52930
European-Finnish (FIN)
AF:
0.00748
AC:
197
AN:
26352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4312
European-Non Finnish (NFE)
AF:
0.00355
AC:
3466
AN:
975508
Other (OTH)
AF:
0.00278
AC:
127
AN:
45620
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00240
AC:
358
AN:
149450
Hom.:
1
Cov.:
31
AF XY:
0.00247
AC XY:
180
AN XY:
72964
show subpopulations
African (AFR)
AF:
0.000412
AC:
17
AN:
41214
American (AMR)
AF:
0.00186
AC:
28
AN:
15094
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5054
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.00716
AC:
69
AN:
9638
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00360
AC:
241
AN:
66922
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00128
Hom.:
0
Bravo
AF:
0.00204

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 31, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Coffin-Siris syndrome 1 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
20
DANN
Benign
0.87
PhyloP100
1.5
PromoterAI
-0.029
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374013482; hg19: chr6-157100624; API